IP Library Granted Patent US 10,856,926
Granted Patent B2
US 10,856,926 · App. 16/123,308 · Granted Dec 8, 2020

Neuromodulation for metabolic conditions or syndromes

Inventors: Bobak Robert Azamian (Newport Coast, CA); Jonathan Allen Coe (Menlo Park, CA); Scott Bradley Vafai (Boston, MA)
Assignee: Metavention, Inc.
A61B18/02A61B17/00A61B17/00234A61B17/32A61B18/04A61B18/06A61B18/1492A61B18/1815A61B18/20A61B18/24A61K9/0019A61K31/045A61K31/05A61K31/395A61K33/30A61K45/06A61M5/14A61N1/0551A61N5/00A61N7/00A61B2017/00318A61B2017/32007A61B2017/320069A61B2018/0022A61B2018/00023A61B2018/00214A61B2018/00404A61B2018/00434A61B2018/00529A61B2018/00577A61B2018/00732A61B2018/00791A61B2018/00839A61B2018/00994A61B2018/0212A61B2018/048A61B2018/1861A61N7/022
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,856,926
App. No.
16/123,308
Granted
Dec 8, 2020
Kind
B2
Abstract

According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.

Claims (52)

1. A method of facilitating hepatic neuromodulation using a laparoscopic approach, the method comprising:

laparoscopically delivering a radiofrequency energy delivery device within a subject;

positioning a distal portion of the radiofrequency energy delivery device at a location adjacent a portion of a common hepatic artery,

wherein the distal portion of the radiofrequency energy delivery device comprises at least one electrode; and

causing radiofrequency energy to be applied by the at least one electrode to one or more nerves of a hepatic plexus sufficient to ablate the one or more nerves in a manner that facilitates a reduction in at least one of a blood glucose level or a lipoprotein level in the subject; and

removing the radiofrequency energy delivery device from the subject.

2. The method of claim 1 ,

wherein the radiofrequency energy is in a range of 50 kHz to 5 MHz,

wherein the radiofrequency energy heats the one or more nerves to a temperature of up to 90 degrees Celsius; and

wherein the one or more nerves are sympathetic nerves of the hepatic plexus.

3. The method of claim 1 , further comprising confirming ablation of the one or more nerves.

4. The method of claim 1 , further comprising maintaining contact between the at least one electrode and the portion of common hepatic artery at a contact pressure of between 0.1 g/mm 2 and 10 g/mm 2 .

5. A method of facilitating hepatic neuromodulation using a laparoscopic approach, the method comprising:

laparoscopically delivering an ablation device within a subject;

positioning a distal portion of the ablation device at a location adjacent a portion of a common hepatic artery,

ablating one or more nerves surrounding the common hepatic artery using the ablation device in a manner that facilitates a reduction in at least one of a blood glucose level or a lipoprotein level in the subject; and

removing the ablation device from the subject.

6. The method of claim 5 :

wherein the ablation device comprises a radiofrequency energy delivery device comprising a plurality of electrodes,

wherein each of the plurality of electrodes is configured to operate as a monopolar electrode;

wherein ablating the one or more nerves comprises applying radiofrequency energy having a frequency within a range between 50 kHz and 5 MHz,

wherein the radiofrequency energy heats the one or more nerves to a temperature of up to 90 degrees Celsius; and

wherein the one or more nerves are sympathetic nerves of a hepatic plexus.

7. The method of claim 5 :

wherein the ablation device comprises an ultrasound energy delivery device comprising at least one ultrasound transducer;

wherein ablating the one or more nerves comprises applying ultrasonic energy having a frequency within a range of 20 kHz to 20 MHz, and

wherein the one or more nerves are sympathetic nerves of a hepatic plexus.

8. The method of claim 5 , wherein ablating the one or more nerves comprises applying ultrasonic energy to the one or more nerves.

9. The method of claim 5 , wherein ablating the one or more nerves comprises applying microwave energy to the one or more nerves.

10. The method of claim 5 , wherein ablating the one or more nerves comprises applying laser energy to the one or more nerves.

11. The method of claim 5 , wherein ablating the one or more nerves comprises applying chemoablation to the one or more nerves.

12. The method of claim 5 , wherein ablating the one or more nerves comprises applying cryoablation to the one or more nerves.

13. A method of facilitating hepatic neuromodulation using a laparoscopic approach, the method comprising:

laparoscopically delivering a neuromodulation device within a subject;

positioning a distal portion of the neuromodulation device at a location adjacent a portion of a hepatic artery,

modulating one or more nerves surrounding the hepatic artery using the neuromodulation device sufficient to treat at least one of a metabolic condition, disorder or disease; and

removing the neuromodulation device from the subject.

14. The method of claim 13 ,

wherein the neuromodulation device comprises a radiofrequency energy delivery device comprising at least one electrode,

wherein modulating the one or more nerves comprises applying radiofrequency energy having a frequency within a range between 50 kHz and 5 MHz to the one or more nerves,

wherein the hepatic artery is a common hepatic artery, and

wherein the one or more nerves are sympathetic nerves of a hepatic plexus.

15. The method of claim 13 :

wherein the neuromodulation device comprises an ultrasound energy delivery device comprising at least one ultrasound transducer,

wherein the hepatic artery is a common hepatic artery,

wherein modulating the one or more nerves comprises applying ultrasonic energy to the one or more nerves, and

wherein the one or more nerves are sympathetic nerves of a hepatic plexus.

16. The method of claim 13 , wherein modulating the one or more nerves comprises applying ultrasonic energy to the one or more nerves.

17. The method of claim 13 , wherein modulating the one or more nerves comprises applying microwave energy to the one or more nerves.

18. The method of claim 13 , wherein modulating the one or more nerves comprises applying laser energy to the one or more nerves.

19. The method of claim 13 , wherein modulating the one or more nerves comprises ablating the one or more nerves.

20. The method of claim 13 , wherein modulating the one or more nerves comprises stimulating the one or more nerves.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2023
From: METAVENTION, INC.
To: MEDTRONIC IRELAND MANUFACTURING UNLIMITED COMPANY
Reel/Frame 064987/0161 →
RELEASE OF SECURITY INTEREST Recorded Aug 22, 2023
From: CUSTOMERS BANK (SUCCESSOR IN INTEREST TO SIGNATURE BANK)
To: METAVENTION, INC.
Reel/Frame 064670/0039 →
SECURITY INTEREST Recorded Jan 11, 2023
From: METAVENTION, INC.
To: RVLHC II, LLC, AS COLLATERAL AGENT
Reel/Frame 062349/0859 →
SECURITY INTEREST Recorded Oct 31, 2022
From: METAVENTION, INC.
To: RVLHC II, LLC, AS COLLATERAL AGENT
Reel/Frame 061602/0249 →
SECURITY INTEREST Recorded Oct 7, 2022
From: METAVENTION, INC.
To: SIGNATURE BANK
Reel/Frame 061341/0724 →
SECURITY INTEREST Recorded Jun 29, 2022
From: METAVENTION, INC.
To: RVLHC II, LLC, AS COLLATERAL AGENT
Reel/Frame 060358/0417 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2022
From: AZAMIAN, BOBAK ROBERT; COE, JONATHAN ALLEN; VAFAI, SCOTT BRADLEY
To: METAVENTION, INC.
Reel/Frame 059137/0742 →
Continuity (7)
Continuation 15159616 · May 19, 2016
Continuation 14870861 · Sep 30, 2015
Continuation 14076008 · Nov 8, 2013
Continuation 13789509 · Mar 7, 2013
Continuation PCTUS2012068630 · Dec 7, 2012
Provisional Application 61568843 · Dec 9, 2011
Related Publication 20190069942A1 · Mar 7, 2019
Cited By (7)
US 12,186,011 US 12,239,365 US 12,408,974 US 12,426,948 US 12,478,806 US 12,539,167 US 12,569,680